Literature DB >> 23678786

Cancer care coordinator: promoting multidisciplinary care--a pilot study in Australian general practice.

Moyez Jiwa1, Glenys Longman, Deepa Sriram, Jill Sherriff, Kathy Briffa, Toni Musiello.   

Abstract

AIM: We hypothesised that patients treated for breast cancer would benefit from targeted therapeutic action delivered by general practitioners on the recommendations of a multidisciplinary team based in primary care.
METHODS: Patients scheduled for follow-up visits at a hospital surgical clinic were invited to complete a self-administered care needs assessment and be interviewed by a breast care nurse. Members of the multidisciplinary team discussed the audio-recorded interviews within 2 weeks. The team made recommendations for each patient, which were presented to the general practitioner as a suggested 'care plan'. Health status information was collected via the Short Form 36 and Anxiety and Depression data via the Hospital anxiety and Depression Scale at recruitment and 3 months later.
RESULTS: Among the 74 women who were invited to participate, 21 were recruited over a 6-month period (28%), 19 of whom completed the study (90%). The mean age was 55 years (range 38-61 years) and the mean time in follow-up was 23 months (range 16-38 months). The team identified a median of three problems per patient (range 2-7) and made an average of two recommendations per patient for referral to an allied health professional (range 0-5). At 3 months, 17 women had attended their general practitioner, 11 of whom felt their condition had improved as a result of the intervention. There was no significant change in Short Form 36 or Hospital Anxiety and Depression Scale score after the intervention.
CONCLUSIONS: Primary care-based multidisciplinary review of treated breast cancer patients is feasible and, for most, results in benefit. However, only a minority of eligible patients participated in this pilot study and the logistics of organising the reviews warrants careful consideration.

Entities:  

Mesh:

Year:  2013        PMID: 23678786     DOI: 10.1016/j.colegn.2012.03.007

Source DB:  PubMed          Journal:  Collegian        ISSN: 1322-7696            Impact factor:   2.573


  7 in total

Review 1.  Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes.

Authors:  J Shao; M Rodrigues; A L Corter; N N Baxter
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

2.  The health of women treated for breast cancer: A challenge in primary care.

Authors:  Moyez Jiwa; Arleen Chan; Jaco Loriet; Shohreh Razmi
Journal:  Australas Med J       Date:  2012-06-30

3.  The common characteristics and outcomes of multidisciplinary collaboration in primary health care: a systematic literature review.

Authors:  Sanneke Schepman; Johan Hansen; Iris D de Putter; Ronald S Batenburg; Dinny H de Bakker
Journal:  Int J Integr Care       Date:  2015-06-24       Impact factor: 5.120

4.  Construction and validation of the quality of oncology nursing care scale (QONCS).

Authors:  Andreas Charalambous; Theodoula Adamakidou
Journal:  BMC Nurs       Date:  2014-12-19

Review 5.  Interventions to improve care coordination between primary healthcare and oncology care providers: a systematic review.

Authors:  Jennifer R Tomasone; Melissa C Brouwers; Marija Vukmirovic; Eva Grunfeld; Mary Ann O'Brien; Robin Urquhart; Melanie Walker; Fiona Webster; Margaret Fitch
Journal:  ESMO Open       Date:  2016-09-06

6.  What sort of follow-up services would Australian breast cancer survivors prefer if we could no longer offer long-term specialist-based care? A discrete choice experiment.

Authors:  T Bessen; G Chen; J Street; J Eliott; J Karnon; D Keefe; J Ratcliffe
Journal:  Br J Cancer       Date:  2014-01-14       Impact factor: 7.640

7.  Integrated Care Planning for Cancer Patients: A Scoping Review.

Authors:  Anum Irfan Khan; Erin Arthurs; Sharon Gradin; Marnie MacKinnon; Jonathan Sussman; Vishal Kukreti
Journal:  Int J Integr Care       Date:  2017-11-13       Impact factor: 5.120

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.